Jamie Christensen, EVP, Chief Scientific Officer at Mirati Therapeutics, Inc. (MRTX), sold 3,898 shares at $46.60 ($182K) on 2023-01-04, disclosed to the SEC on 2023-01-05.
Seasonal sale ($182k) by EVP, Chief Scientific Officer — this insider has traded MRTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.60 | 1,949 | $91K | 50.0% |
| 2 | $46.60 | 1,949 | $91K | 50.0% |
| Total | $46.60 avg | 3,898 | $182K | 100% |
| Filing → |
| MRTX | SELL | 2023-12-19 | $275K | — | Filing → |
| MRTX | SELL | 2023-09-12 | $170K | — | Filing → |
| MRTX | SELL | 2023-05-24 | $28K | — | Filing → |